Hair loss remains a critical issue with only a marginal rate of success. A team of researchers from Australia, Singapore, and ...

John Seymour, MBBS, FRACP, PhD, explains why BCL-2 was considered an undruggable target for so long and what led to the development of effective BCL-2 inhibitors.

Alopecia is an autoimmune disorder that causes non-scarring hair loss on the scalp and body that is experienced by almost 2% ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The combination of the BCL-2/BCL-XL inhibitor APG-1252 with lapatinib synergistically inhibits the AKT/GSK-3β/MCL-1 signaling pathway, leading to a decrease in mitochondrial membrane potential ...